APA

Goldstein J. A., Ishizaki T., Chiba K., de Morais S. M., Bell D., Krahn P. M. & Evans D. A. (19970724). Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations. : Pharmacogenetics.

Chicago

Goldstein J A, Ishizaki T, Chiba K, de Morais S M, Bell D, Krahn P M and Evans D A. 19970724. Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations. : Pharmacogenetics.

Harvard

Goldstein J. A., Ishizaki T., Chiba K., de Morais S. M., Bell D., Krahn P. M. and Evans D. A. (19970724). Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations. : Pharmacogenetics.

MLA

Goldstein J A, Ishizaki T, Chiba K, de Morais S M, Bell D, Krahn P M and Evans D A. Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations. : Pharmacogenetics. 19970724.